Sign in
Companies / PODD vs BDX

PODD vs BDX: Insulet and Becton Dickinson

Medical Devices
Compare more companies

Insulet (PODD) reported $2.7B in revenue against a 9.1% net margin, while Becton Dickinson (BDX) reported $21.8B at a 7.7% net margin, most recently.

MetricPODDBDX
Revenue$2.7B$21.8B
Net Income$0.2B$1.7B
Gross Margin71.6%45.4%
Operating Margin17.5%11.8%
EPS (Diluted)$3.48$5.82
Free Cash Flow$0.4B$2.7B
Total Debt$0.9B$19.2B
P/E Ratio81.7×32.2×
P/B Ratio13.2×n/m
Stock Price$153.92$211.95
Free: last 5 years
Fiscal yearFY2009 🔒FY2010 🔒FY2011 🔒FY2012 🔒FY2013 🔒FY2014 🔒FY2015 🔒FY2016 🔒FY2017 🔒FY2018 🔒FY2019 🔒FY2020 🔒FY2021FY2022FY2023FY2024FY2025
PODD Revenue••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••$1.1B$1.3B$1.7B$2.1B$2.7B
BDX Revenue••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••$19.1B$18.9B$19.4B$20.2B$21.8B

More on PODD

More on BDX

Other comparisons